Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: AtriCure, Inc.

Market Cap 145.85Cr 127.16Cr 117.77Cr 110.25Cr 206.77Cr 14TCr 208.02Cr 1.4TCr 541.48Cr 6.77TCr 547.46Cr 535.72Cr 24TCr P/E 2026 *
628x
P/E 2027 * 84.7x
Enterprise Value 130.25Cr 113.56Cr 105.18Cr 98Cr 184.65Cr 12TCr 185.77Cr 1.25TCr 483.57Cr 6.05TCr 488.91Cr 478.42Cr 21TCr EV / Sales 2026 *
2.15x
EV / Sales 2027 * 1.81x
Free-Float
96.14%
Yield 2026 *
-
Yield 2027 * -
1 day+6.19%
1 week+0.03%
Current month+4.08%
1 month-0.07%
3 months-1.29%
6 months-29.67%
Current year-27.20%
1 week 26.81
Extreme 26.81
29.03
1 month 25.36
Extreme 25.36
29.27
Current year 25.36
Extreme 25.36
43.18
1 year 25.36
Extreme 25.36
43.18
3 years 18.94
Extreme 18.94
59.61
5 years 18.94
Extreme 18.94
89.18
10 years 13.45
Extreme 13.45
89.18
Manager TitleAgeSince
Chief Executive Officer 55 02/11/2012
Director of Finance/CFO 48 01/07/2014
Chief Tech/Sci/R&D Officer 59 18/07/2017
Director TitleAgeSince
Director/Board Member 55 02/11/2012
Director/Board Member 64 11/03/2013
Director/Board Member 75 10/11/2016
Date Insider Type Main position Quantity % Market Cap.
20/05Sell

Director

-3,000 0.0059%
18/05Free

Director

6,144 0.0121%
18/05Free

Director

6,144 0.0121%
Change 5-day change 1-year change 3-year change Capi.($)
+6.19%+0.03%-8.28%-40.96% 145.85Cr
-0.10%+0.26%-33.52%-16.79% 15TCr
+1.54%-1.07%-8.11%-10.17% 10TCr
-0.07%+2.16%+59.94%+59.84% 5.65TCr
-1.90%-3.49%-7.43%+46.28% 5.29TCr
+1.67%-1.55%-14.51%-44.04% 3.97TCr
-1.32%-1.83% - - 3.04TCr
+1.74%-3.85%-9.41%-43.32% 2.8TCr
+1.35%-0.26%+51.96%-11.10% 2.32TCr
+0.83%+0.27%-16.15%-3.65% 2.03TCr
Average +0.98%-1.03%+1.61%-7.10% 5.08TCr
Weighted average by Cap. +0.32%-1.23%-6.21%-2.38%

Financials

2026 *2027 *
Net sales 60Cr 53Cr 49Cr 46Cr 86Cr 5.71TCr 86Cr 579.53Cr 224.6Cr 2.81TCr 227.08Cr 222.21Cr 9.76TCr 68Cr 59Cr 55Cr 51Cr 96Cr 6.4TCr 97Cr 649.96Cr 251.9Cr 3.15TCr 254.68Cr 249.22Cr 11TCr
Net income 26.6L 23.19L 21.48L 20.11L 37.71L 25Cr 37.94L 2.55Cr 98.76L 12Cr 99.85L 97.71L 43Cr 1.75Cr 1.52Cr 1.41Cr 1.32Cr 2.48Cr 164.97Cr 2.49Cr 17Cr 6.49Cr 81Cr 6.56Cr 6.42Cr 281.95Cr
Net Debt -16Cr -14Cr -13Cr -12Cr -22Cr -1.47TCr -22Cr -149.43Cr -58Cr -724.47Cr -59Cr -57Cr -2.52TCr -23Cr -20Cr -19Cr -18Cr -33Cr -2.19TCr -33Cr -222.5Cr -86Cr -1.08TCr -87Cr -85Cr -3.75TCr
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
18/26/18 28.80 $ +6.19% 17,31,572
17/26/17 27.12 $ -3.07% 8,28,896
16/26/16 27.98 $ 0.00% 7,02,635
15/26/15 27.98 $ -2.81% 8,08,461
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
28.80USD
Average target price
47.00USD
Spread / Average Target
+63.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ATRC Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!